Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients After Switching to Tiotropium Plus Olodaterol Fixed Dose Combination in Greece

CompletedOBSERVATIONAL
Enrollment

1,396

Participants

Timeline

Start Date

February 16, 2021

Primary Completion Date

February 21, 2022

Study Completion Date

February 21, 2022

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Tiotropium bromide plus Olodaterol

Tiotropium bromide plus Olodaterol

Trial Locations (2)

185 47

Metropolitan Hospitsal, PNOI Pulmonology Clinic, Athens

555 35

European Interbalkan Medical Center, Pulmonology Clinic, Thessaloniki

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY